Boston Scientific supports cost of its new stent; A clinical trial has yet to show that its Synergy stent outperforms cheaper rivals, but device maker insists time will tell

Byline: JOE CARLSON; STAFF WRITER Boston ScientificÆs ôblockbusterö Synergy stent for opening blocked arteries on the heart commands a higher price than its competitors, but so far the jury is [...]